
Acuitas Therapeutics and Researchers at the University of Pennsylvania Demonstrate Enhanced T Cell Immunity with IL-12 ...
Acuitas Therapeutics and Researchers at the University of Pennsylvania Demonstrate Enhanced T Cell Immunity with IL-12 mRNA-LNP Adjuvant Vancouver, BC, August 1, 2025--(T-Net)--Acuitas Therapeutics has announced the publication of a new study in Science …